List of Excipients in API BUPRENORPHINE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BUPRENORPHINE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Indivior Inc | SUBLOCADE | buprenorphine | 12496-0100 | METHYLPYRROLIDONE | |
| Indivior Inc | SUBLOCADE | buprenorphine | 12496-0100 | POLY(DL-LACTIC-CO-GLYCOLIC ACID) | |
| Rhodes Pharmaceuticals LP | BUPRENORPHINE | buprenorphine | 42858-750 | ETHYL LEVULINATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BUPRENORPHINE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 | CITRIC ACID MONOHYDRATE |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 | LEVULINIC ACID |
| Actavis Pharma Inc | buprenorphine | 0228-3156 | ANHYDROUS CITRIC ACID |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for BUPRENORPHINE
Excipient focus: .ALPHA.-TOCOPHEROL
BUPRENORPHINE drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| American Health Packaging | buprenorphine and naloxone | 60687-626 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-9482 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: .ALPHA.-TOCOPHEROL ACETATE
BUPRENORPHINE drug variants containing .ALPHA.-TOCOPHEROL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing .ALPHA.-TOCOPHEROL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACESULFAME POTASSIUM
BUPRENORPHINE drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
BUPRENORPHINE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Braeburn Inc | buprenorphine | 58284-208 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
BUPRENORPHINE drug variants containing ALUMINUM OXIDE
BUPRENORPHINE drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
BUPRENORPHINE drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
BUPRENORPHINE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DEXTROSE
BUPRENORPHINE drug variants containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine hydrochloride | 0143-9246 |
| Hospira Inc | buprenorphine hydrochloride | 0409-2012 |
| Indivior Inc | buprenorphine hydrochloride | 12496-0757 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
BUPRENORPHINE drug variants containing ANHYDROUS LACTOSE
BUPRENORPHINE drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
BUPRENORPHINE drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYANISOLE
BUPRENORPHINE drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | buprenorphine | 50268-128 |
| Sun Pharmaceutical Industries Inc | buprenorphine | 62756-459 |
| RedPharm Drug Inc | buprenorphine | 67296-1506 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
BUPRENORPHINE drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
BUPRENORPHINE drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
BUPRENORPHINE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| Contract Pharmacy Services-PA | buprenorphine hydrochloride sublingual | 67046-996 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID ACETATE
BUPRENORPHINE drug variants containing CITRIC ACID ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing CITRIC ACID ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
BUPRENORPHINE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| >Company | >Ingredient | >NDC |
Excipient focus: CORN SYRUP
BUPRENORPHINE drug variants containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| American Health Packaging | buprenorphine and naloxone | 60687-626 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-9482 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
BUPRENORPHINE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
BUPRENORPHINE drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE
BUPRENORPHINE drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| American Regent Inc | buprenorphine hydrochloride | 0517-0725 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC POTASSIUM PHOSPHATE
BUPRENORPHINE drug variants containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYL LEVULINATE
BUPRENORPHINE drug variants containing ETHYL LEVULINATE
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| Lake Erie Medical DBA Quality Care Products LLC | buprenorphine | 55700-579 |
| Purdue Pharma LP | buprenorphine | 59011-751 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing ETHYL LEVULINATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
BUPRENORPHINE drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
BUPRENORPHINE drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
BUPRENORPHINE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Clinical Solutions Wholesale LLC | buprenorphine | 58118-3156 |
| REMEDYREPACK INC | buprenorphine | 70518-1625 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
BUPRENORPHINE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
BUPRENORPHINE drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL DIOLEATE
BUPRENORPHINE drug variants containing GLYCERYL DIOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Braeburn Inc | buprenorphine | 58284-208 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing GLYCERYL DIOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
BUPRENORPHINE drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine hydrochloride | 0143-9246 |
| Hospira Inc | buprenorphine hydrochloride | 0409-2012 |
| American Regent Inc | buprenorphine hydrochloride | 0517-0725 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
BUPRENORPHINE drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
BUPRENORPHINE drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
BUPRENORPHINE drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
BUPRENORPHINE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| Indivior Inc | buprenorphine hydrochloride, naloxone hydrochloride | 0781-7216 |
| INDIVIOR INC | buprenorphine hydrochloride, naloxone hydrochloride | 12496-1202 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
BUPRENORPHINE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
BUPRENORPHINE drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| bryant ranch prepack | buprenorphine hydrochloride | 63629-4092 |
| Physicians Total Care Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54868-5750 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
BUPRENORPHINE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
BUPRENORPHINE drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Braeburn Inc | buprenorphine | 58284-208 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: LEVULINIC ACID
BUPRENORPHINE drug variants containing LEVULINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Alvogen Inc | buprenorphine | 47781-406 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine | 50742-372 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing LEVULINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
BUPRENORPHINE drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTITOL
BUPRENORPHINE drug variants containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Indivior Inc | buprenorphine hydrochloride, naloxone hydrochloride | 0781-7216 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
BUPRENORPHINE drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| American Health Packaging | buprenorphine and naloxone | 60687-626 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-9482 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
BUPRENORPHINE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| >Company | >Ingredient | >NDC |
Excipient focus: MENTHOL
BUPRENORPHINE drug variants containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
BUPRENORPHINE drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPYRROLIDONE
BUPRENORPHINE drug variants containing METHYLPYRROLIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing METHYLPYRROLIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| >Company | >Ingredient | >NDC |
Excipient focus: OLEYL OLEATE
BUPRENORPHINE drug variants containing OLEYL OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| Alvogen Inc | buprenorphine | 47781-406 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine | 50742-372 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing OLEYL OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT OIL
BUPRENORPHINE drug variants containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| BioDelivery Sciences International Inc | buprenorphine hydrochloride | 59385-021 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLY(DL-LACTIC-CO-GLYCOLIC ACID)
BUPRENORPHINE drug variants containing POLY(DL-LACTIC-CO-GLYCOLIC ACID)
| Company | Ingredient | NDC |
|---|---|---|
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLY(DL-LACTIC-CO-GLYCOLIC ACID)
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYCARBOPHIL
BUPRENORPHINE drug variants containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
BUPRENORPHINE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| Indivior Inc | buprenorphine hydrochloride, naloxone hydrochloride | 0781-7216 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
BUPRENORPHINE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
BUPRENORPHINE drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| Aidarex Pharmaceuticals LLC | buprenorphine hydrochloride, naloxone hydrochloride | 53217-328 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 100000
BUPRENORPHINE drug variants containing POLYETHYLENE OXIDE 100000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLYETHYLENE OXIDE 100000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 1000000
BUPRENORPHINE drug variants containing POLYETHYLENE OXIDE 1000000
| Company | Ingredient | NDC |
|---|---|---|
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| RedPharm Drug | buprenorphine and naloxone | 67296-2096 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLYETHYLENE OXIDE 1000000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 200000
BUPRENORPHINE drug variants containing POLYETHYLENE OXIDE 200000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLYETHYLENE OXIDE 200000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 2000000
BUPRENORPHINE drug variants containing POLYETHYLENE OXIDE 2000000
| Company | Ingredient | NDC |
|---|---|---|
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| RedPharm Drug | buprenorphine and naloxone | 67296-2096 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLYETHYLENE OXIDE 2000000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 900000
BUPRENORPHINE drug variants containing POLYETHYLENE OXIDE 900000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POLYETHYLENE OXIDE 900000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
BUPRENORPHINE drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
BUPRENORPHINE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| AvPAK | buprenorphine | 50268-128 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine | 50742-372 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K29/32
BUPRENORPHINE drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
BUPRENORPHINE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
BUPRENORPHINE drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine | 47781-406 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
BUPRENORPHINE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
BUPRENORPHINE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
BUPRENORPHINE drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
BUPRENORPHINE drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
BUPRENORPHINE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
BUPRENORPHINE drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
BUPRENORPHINE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | buprenorphine | 50268-128 |
| Sun Pharmaceutical Industries Inc | buprenorphine | 62756-459 |
| Contract Pharmacy Services-PA | buprenorphine | 67046-994 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
BUPRENORPHINE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
BUPRENORPHINE drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| RedPharm Drug | buprenorphine and naloxone | 67296-2096 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
BUPRENORPHINE drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
BUPRENORPHINE drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
BUPRENORPHINE drug variants containing SODIUM STEARYL FUMARATE
BUPRENORPHINE drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
BUPRENORPHINE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
BUPRENORPHINE drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
BUPRENORPHINE drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
BUPRENORPHINE drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
BUPRENORPHINE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Hikma Pharmaceuticals USA Inc | buprenorphine hcl | 0054-0176 |
| Major Pharmaceuticals | buprenorphine hcl | 0904-7154 |
| >Company | >Ingredient | >NDC |
BUPRENORPHINE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
